180 related articles for article (PubMed ID: 18001476)
1. Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines.
Winter H; van den Engel NK; Rüttinger D; Schmidt J; Schiller M; Poehlein CH; Löhe F; Fox BA; Jauch KW; Hatz RA; Hu HM
J Transl Med; 2007 Nov; 5():56. PubMed ID: 18001476
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptor.
Winter H; van den Engel NK; Poehlein CH; Hatz RA; Fox BA; Hu HM
J Transl Med; 2007 Mar; 5():14. PubMed ID: 17355640
[TBL] [Abstract][Full Text] [Related]
3. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
Winter H; Hu HM; Urba WJ; Fox BA
J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy.
Winter H; Hu HM; McClain K; Urba WJ; Fox BA
J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488
[TBL] [Abstract][Full Text] [Related]
5. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells.
Poehlein CH; Hu HM; Yamada J; Assmann I; Alvord WG; Urba WJ; Fox BA
J Immunol; 2003 Feb; 170(4):2004-13. PubMed ID: 12574370
[TBL] [Abstract][Full Text] [Related]
6. Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma.
Kunz M; Toksoy A; Goebeler M; Engelhardt E; Bröcker E; Gillitzer R
J Pathol; 1999 Dec; 189(4):552-8. PubMed ID: 10629557
[TBL] [Abstract][Full Text] [Related]
7. Differential chemokine response of murine macrophages stimulated with cytokines and infected with Listeria monocytogenes.
Flesch IE; Barsig J; Kaufmann SH
Int Immunol; 1998 Jun; 10(6):757-65. PubMed ID: 9678756
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells.
Roda JM; Parihar R; Magro C; Nuovo GJ; Tridandapani S; Carson WE
Cancer Res; 2006 Jan; 66(1):517-26. PubMed ID: 16397268
[TBL] [Abstract][Full Text] [Related]
9. Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studies.
Winter H; Hu HM; Poehlein CH; Huntzicker E; Osterholzer JJ; Bashy J; Lashley D; Lowe B; Yamada J; Alvord G; Urba WJ; Fox BA
Immunology; 2003 Mar; 108(3):409-19. PubMed ID: 12603608
[TBL] [Abstract][Full Text] [Related]
10. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
[TBL] [Abstract][Full Text] [Related]
11. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.
Dorner BG; Scheffold A; Rolph MS; Huser MB; Kaufmann SH; Radbruch A; Flesch IE; Kroczek RA
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6181-6. PubMed ID: 11972057
[TBL] [Abstract][Full Text] [Related]
12. A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages.
Tang KF; Tan SY; Chan SH; Chong SM; Loh KS; Tan LK; Hu H
Hum Pathol; 2001 Jan; 32(1):42-9. PubMed ID: 11172294
[TBL] [Abstract][Full Text] [Related]
13. Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type 2 to a type 1 cytokine profile.
Hu HM; Urba WJ; Fox BA
J Immunol; 1998 Sep; 161(6):3033-41. PubMed ID: 9743368
[TBL] [Abstract][Full Text] [Related]
14. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection.
Lacroix-Lamandé S; Mancassola R; Naciri M; Laurent F
Infect Immun; 2002 Apr; 70(4):2090-9. PubMed ID: 11895975
[TBL] [Abstract][Full Text] [Related]
15. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo.
Kopydlowski KM; Salkowski CA; Cody MJ; van Rooijen N; Major J; Hamilton TA; Vogel SN
J Immunol; 1999 Aug; 163(3):1537-44. PubMed ID: 10415057
[TBL] [Abstract][Full Text] [Related]
16. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
[TBL] [Abstract][Full Text] [Related]
18. T-cell mediated induction of allogeneic endothelial cell chemokine expression.
Kobayashi H; Koga S; Novick AC; Toma H; Fairchild RL
Transplantation; 2003 Feb; 75(4):529-36. PubMed ID: 12605122
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokines induce NF-kappaB-dependent/NO-independent chemokine gene expression in MIN6 beta cells.
Baker MS; Chen X; Rotramel A; Nelson J; Kaufman DB
J Surg Res; 2003 Mar; 110(1):295-303. PubMed ID: 12697414
[TBL] [Abstract][Full Text] [Related]
20. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.
Kershaw MH; Wang G; Westwood JA; Pachynski RK; Tiffany HL; Marincola FM; Wang E; Young HA; Murphy PM; Hwu P
Hum Gene Ther; 2002 Nov; 13(16):1971-80. PubMed ID: 12427307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
